Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation Article Proceedings Paper

cited authors

  • Arquette, M; Wasserman, T; Govindan, R; Garfield, D; Senzer, N; Gillenwater, H; Socinski, M

authors

Publication Date

  • January 1, 2002

webpage

published in

category

start page

  • 59

end page

  • 61

volume

  • 12

issue

  • 1